Skip Nav Destination
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia
Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphoma
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL
Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myeloma
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia
Issue Archive
April 11 2023
In this Issue
Table of Contents
CLINICAL TRIALS AND OBSERVATIONS
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia
Clinical Trials & Observations
Shai Shimony,Yiwen Liu,Yannis K. Valtis,Jonathan D. Paolino,Andrew E. Place,Andrew M. Brunner,Lachelle D. Weeks,Lewis B. Silverman,Lynda M. Vrooman,Donna S. Neuberg,Richard M. Stone,Daniel J. DeAngelo,Marlise R. Luskin
Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphoma
Clinical Trials & Observations
Jeremy S. Abramson,Elizabeth Bengston,Robert Redd,Jeffrey A. Barnes,Tak Takvorian,Lubomir Sokol,Frederick Lansigan,Philippe Armand,Bijal Shah,Eric Jacobsen,Rosalba Martignetti,Elyce Turba,Sara Metzler,Victoria Patterson,Ann S. LaCasce,Celeste M. Bello
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL
Clinical Trials & Observations
Pallawi Torka,Adrienne Groman,Jerry Wong,Jenna Nichols,Angela Kader,Cory Mavis,Andrea Anampa-Guzmán,Sheila Jani Sait,AnneMarie Block,Eugene Przespolewski,Alice Mohr,Ian Lund,Kenneth McWhite,Jessica Kostrewa,Joseph DeMarco,Michael Johnson,Andrea Darrall,Roshneke Thomas,Suchitra Sundaram,Paola Ghione,Alan Hutson,Francisco J. Hernandez-Ilizaliturri
HEALTH SERVICES AND OUTCOMES
Coping in caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation
Hermioni L. Amonoo,P. Connor Johnson,Ashley M. Nelson,Madison A. Clay,Elizabeth Daskalakis,Richard A. Newcomb,Emma C. Deary,Elizabeth F. Mattera,Daniel Yang,Katherine Cronin,Kofi Boateng,Stephanie J. Lee,Thomas W. LeBlanc,Areej El-Jawahri
HEMATOPOIESIS AND STEM CELLS
Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control study
Carin L. E. Hazenberg,Aniek O. de Graaf,René Mulder,Laura B. Bungener,Maaike G. J. M. van Bergen,André B. Mulder,Goda Choi,Jan Jacob Schuringa,Marco R. de Groot,Edo Vellenga,Joop H. Jansen,Gerwin Huls,Isabelle A. van Zeventer
IMMUNOBIOLOGY AND IMMUNOTHERAPY
Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myeloma
Clinical Trials & Observations
Taiga Nishihori,James E. Hoffman,Anne Huff,Gurpreet S. Kapoor,Ioanna Eleftheriadou,Stefan Zajic,Alisa Urbano,Sunil Suchindran,Michael Chisamore,Jimson W. D’Souza,Thomas Faitg,Aaron P. Rapoport
LYMPHOID NEOPLASIA
FBXW7β isoform drives transcriptional activation of the proinflammatory TNF cluster in human pro-B cells
Scarlett Y. Yang,Katharina E. Hayer,Hossein Fazelinia,Lynn A. Spruce,Mukta Asnani,Kathryn L. Black,Ammar S. Naqvi,Vinodh Pillai,Yoseph Barash,Kojo S. J. Elenitoba-Johnson,Andrei Thomas-Tikhonenko
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL
Clinical Trials & Observations
Hua-Jay J. Cherng,Stefan K. Alig,Yasuhiro Oki,Loretta J. Nastoupil,Luis Fayad,Sattva S. Neelapu,Francesco Turturro,Fredrick Hagemeister,Alexander F. M. Craig,Charles W. Macaulay,Maria Alma Rodriguez,Hun Ju Lee,Timothy J. McDonnell,Christopher R. Flowers,Francisco Vega,Michael R. Green,Lei Feng,David M. Kurtz,Ash A. Alizadeh,R. Eric Davis,Jason R. Westin
Impact of mesenchymal stromal cell–derived vesicular cargo on B-cell acute lymphoblastic leukemia progression
Christina Karantanou,Valentina R. Minciacchi,Rahul Kumar,Costanza Zanetti,Jimena Bravo,Raquel S. Pereira,Georg Tascher,Tobias Tertel,Adriana Covarrubias-Pinto,Katrin Bankov,Lisa-Marie Pfeffermann,Halvard Bonig,Paola Divieti-Pajevic,David G. McEwan,Bernd Giebel,Christian Münch,Ivan Dikic,Daniela S. Krause
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia
Clinical Trials & Observations
Anjali S. Advani,Anna Moseley,Kristen M. O’Dwyer,Brent L. Wood,Jae Park,Matthew Wieduwilt,Deepa Jeyakumar,George Yaghmour,Ehab L. Atallah,Aaron T. Gerds,Susan M. O'Brien,Jane L. Liesveld,Megan Othus,Mark Litzow,Richard M. Stone,Elad Sharon,Harry P. Erba
MYELOID NEOPLASIA
Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemia
Danielle C. Kirkey,Anisha M. Loeb,Sommer Castro,Cyd Nourigat McKay,LaKeisha Perkins,Laura Pardo,Amanda R. Leonti,Thao T. Tang,Michael R. Loken,Lisa Eidenschink Brodersen,Keith R. Loeb,David A. Scheinberg,Quy Le,Soheil Meshinchi
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
Sofia von Palffy,Hanna Thorsson,Pablo Peña-Martínez,Noelia Puente-Moncada,Carl Sandén,Anna M. Blom,Rasmus Henningsson,Gunnar Juliusson,Ben King,Niklas Landberg,Vladimir Lazarevic,Christina Orsmark-Pietras,Marianne Rissler,Vendela Rissler,Helena Ågerstam,Marcus Järås,Henrik Lilljebjörn,Thoas Fioretos
Optical genome mapping in acute myeloid leukemia: a multicenter evaluation
Brynn Levy,Linda B. Baughn,Yassmine Akkari,Scott Chartrand,Brandon LaBarge,David Claxton,P. Alan Lennon,Claudia Cujar,Ravindra Kolhe,Kate Kroeger,Beth Pitel,Nikhil Sahajpal,Malini Sathanoori,George Vlad,Lijun Zhang,Min Fang,Rashmi Kanagal-Shamanna,James R. Broach
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
PLATELETS AND THROMBOPOIESIS
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSFUSION MEDICINE
TRANSPLANTATION
Posttransplantation cyclophosphamide expands functional myeloid-derived suppressor cells and indirectly influences Tregs
Rochelle E. Fletcher,Natalia S. Nunes,Michael T. Patterson,Natasha Vinod,Shanzay M. Khan,Suresh K. Mendu,Xianghong Li,Alessandra de Paula Pohl,Lucas P. Wachsmuth,Hyoyoung Choo-Wosoba,Michael A. Eckhaus,David J. Venzon,Christopher G. Kanakry
Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use
Daniela Weber,Markus Weber,Elisabeth Meedt,Sakhila Ghimire,Daniel Wolff,Matthias Edinger,Hendrik Poeck,Andreas Hiergeist,André Gessner,Francis Ayuk,Wolf Roesler,Matthias Wölfl,Sabrina Kraus,Robert Zeiser,Hannah Bertrand,Peter Bader,Evelyn Ullrich,Matthias Eder,Sigrun Gleich,Rachel Young,Wolfgang Herr,John E. Levine,James L. M. Ferrara,Ernst Holler
RESEARCH LETTERS
Elevated RIPK3 correlates with disease burden in myelofibrosis
Veronika Dill,Celina V. Wagner,Eva C. Keller,Francisco Jose Fernandez-Hernandez,Khalid Shoumariyeh,Timo O. Odinius,Lars Buschhorn,Richard T. Hauch,Christian Suren,Judith S. Hecker,Peter Herhaus,Michael Sandherr,Burkhard Schmidt,Julia Slotta-Huspenina,Florian Bassermann,Ulrike Höckendorf,Stefanie Jilg,Caterina Branca,Sebastian Vosberg,Philipp J. Jost
EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
Yong Li,Zijun Y. Xu-Monette,Jeremy Abramson,Aliyah R. Sohani,Govind Bhagat,Alexandar Tzankov,Carlo Visco,Shanxiang Zhang,Karen Dybkaer,Zenggang Pan,Min Xu,Wayne Tam,Youli Zu,Eric D. Hsi,Fredrick B. Hagemeister,Heounjeong Go,J. Han van Krieken,Jane N. Winter,Maurilio Ponzoni,Andrés J. M. Ferreri,Michael B. Møller,Miguel A. Piris,Yingjun Wang,Mingzhi Zhang,Ken H. Young
-
Cover Image
Cover Image
Hematoxylin and eosin staining show that administration of anti–G-CSF antibody reduced neutrophil infiltration in mouse lungs with chronic granulomatous disease after challenge with fungal cell walls (zymosan particles). See the article by Song et al.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Advertisement intended for health care professionals